Search
Search
About
Log in
Join
Experiences with
Osimertinib
Posts
Communities
30 public posts
Filter results
Tagrisso prolongs progression free survival in resectable EGFR patients.
https://www.asco.org/about-asco/press-center/news-releases/post-surgery-
osimertinib
-delays-disease-recurrence-patients
https://www.asco.org/about-asco/press-center/news-releases/post-surgery-
osimertinib
-delays-disease-recurrence-patients
Denzie
Volunteer
in
Lung Cancer Support
4 years ago
EGFR mutations on exon 20 and exon 21
I'm starting treatment on
osimertinib
, how effective is this treatment?
I'm starting treatment on
osimertinib
, how effective is this treatment?
Ssbastos
in
Lung Cancer Support
5 years ago
Osimertinib
Does anyone has experience with
Osimertinib
? We are so lucky to find that Dad does not need Chemo and can right to a pill🙏🏻
Does anyone has experience with
Osimertinib
? We are so lucky to find that Dad does not need Chemo and can right to a pill🙏🏻
litoreggie
in
Lung Cancer Support
6 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Video about a lung cancer clinical trial by the New England Journal of Medicine
Results of a clinical trial of an EGFR-agent called
osimertinib
was recently published in the New England Journal of Medicine. A short video was made to discuss this important trial.
Results of a clinical trial of an EGFR-agent called
osimertinib
was recently published in the New England Journal of Medicine. A short video was made to discuss this important trial.
MFH_Advocate
in
Lung Cancer Support
7 years ago
Gefitinib break. 2 new tumours
I am now back on the full dose while we wait for test results for
osimertinib
and immunotherapy treatments. Has anyone had any experience of taking a short break and their cancer recurring or growing in such a short time.
I am now back on the full dose while we wait for test results for
osimertinib
and immunotherapy treatments. Has anyone had any experience of taking a short break and their cancer recurring or growing in such a short time.
Readhill
in
The Roy Castle Lung Cancer Foundation
7 years ago
Tagrisso/Osimertinib side-effects?? Nails lifting???
Hi all - I have been fortunate to have been given Iressa/Gefitinib as first line treatment for stage 4 lung cancer. I had been on that almost 3 years when the cancer started to grow again. Found to have T790M mutation and put on Tagrisso three months ago - good shrinkage of all tumours from latest scan
Hi all - I have been fortunate to have been given Iressa/Gefitinib as first line treatment for stage 4 lung cancer. I had been on that almost 3 years when the cancer started to grow again. Found to have T790M mutation and put on Tagrisso three months ago - good shrinkage of all tumours from latest scan
dizzie-wh
in
The Roy Castle Lung Cancer Foundation
7 years ago
A Lung Cancer Blogger's Story
My treatments to date: erlotinib for 10 months, then a phase 2 clinical trial of rociletinib for 8 months, and most recently
osimertinib
for 8 months and counting. I am currently feeling shockingly well. I am a realist, however, and know that this lovely period will not last forever.
My treatments to date: erlotinib for 10 months, then a phase 2 clinical trial of rociletinib for 8 months, and most recently
osimertinib
for 8 months and counting. I am currently feeling shockingly well. I am a realist, however, and know that this lovely period will not last forever.
scifiknitter
Blogger
in
Lung Cancer Support
8 years ago
Osimertinib (Tagrisso)
This time the Scottish Medicine Consortium have asked us to do submissions on behalf of patients on
Osimertinib
(Tagrisso). Please if you are currently on a trial or being considered for it get in touch, we need quotes (as many as possible) we need to know how it compares with existing treatments.
This time the Scottish Medicine Consortium have asked us to do submissions on behalf of patients on
Osimertinib
(Tagrisso). Please if you are currently on a trial or being considered for it get in touch, we need quotes (as many as possible) we need to know how it compares with existing treatments.
NicF4
Administrator
in
The Roy Castle Lung Cancer Foundation
8 years ago
FDA approves another blood test for a mutation (T790M) in lung cancer
The test that was just approved is a companion test for
osimertinib
(Tagrisso®), which is approved for use in patients whose lung cancer has the T790M mutation. The T790M mutation is linked to resistance to EGFR-targeting drugs.
The test that was just approved is a companion test for
osimertinib
(Tagrisso®), which is approved for use in patients whose lung cancer has the T790M mutation. The T790M mutation is linked to resistance to EGFR-targeting drugs.
MFH_Advocate
in
Lung Cancer Support
8 years ago
Have you been given Pembrolizumab (Keytruda) or Osimertinib (Tagrisso)
This time the Scottish Medicine Consortium have asked us to do submissions on behalf of patients on Prembrolizumab (Keytruda) and
Osimertinib
(Tagrisso).
This time the Scottish Medicine Consortium have asked us to do submissions on behalf of patients on Prembrolizumab (Keytruda) and
Osimertinib
(Tagrisso).
NicF4
Administrator
in
The Roy Castle Lung Cancer Foundation
8 years ago
1
2
Filter results
Clear filters
Posted in
All communities
The Roy Castle Lung Cancer Foundation
16 results
Lung Cancer Support
10 results
Lung Conditions Community Forum
2 results
View top 10 communities
Sort by
Most Relevant
Newest